The Sweet Side of Constipation: Colonic Motor Dysfunction in Diabetes Mellitus
Open accessThe DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
Abstract
Background/Objectives: Chronic constipation is a prevalent gastrointestinal (GI) disorder among individuals with diabetes mellitus (DM), occurring more often than in healthy subjects. This review provides a systematic overview of this often-underestimated clinical condition in people with DM. Methods: A narrative review of literature up to 30 May 2025 was conducted, focusing on studies regarding the pathogenesis of constipation in DM, the correlation with GLP-1 RAs treatment, and the diagnostic-therapeutic framework. Results: The mechanisms underlying constipation in DM remain largely unclear; however, a multifactorial etiology has been proposed, involving structural changes in various tissues within the GI tract wall, as well as functional abnormalities, often secondary to hyperglycemia. It is noteworthy that the use of GLP-1 RAs, a class of medications crucial for managing glycemic control and reducing cardiovascular and renal risk in type 2 DM, is another cause of constipation. The diagnosis of constipation is typically based on clinical evaluation, as validated methods for assessing colonic transit are invasive and available only in specialized centers. Treatment objectives include alleviating symptoms and restoring bowel function. The primary strategy for management involves dietary changes and physical activity. If the clinical response is inadequate, the use of laxatives is recommended. Finally, newer agents and mechanical methods may be considered for scenarios that are particularly severe. Conclusions: Given the increasing global prevalence of DM, healthcare professionals must recognize the clinical problem constituted by the occurrence of chronic constipation, especially considering the use of medications such as GLP-1 RAs that may induce this clinical condition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Notably, data from the FDA Adverse Event Reporting System indicate a lower incidence of nausea and vomiting, potentially due to GIP receptor-mediated neuronal inhibition in the area postrema [149,150], whereas constipation appears more frequent, with the underlying mechanisms yet to be fully elucidated [151].”
From Nutrition and Physical Activity in Optimizing Weight Loss and Lean Mass Preservation in the Incretin-Based Medications Era: A Narrative Review (2025) · cites this paper as [151]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults
Larsen, N., Vogensen, F. K., van den Berg, F. W. J., Nielsen, D. S., Andreasen, A. S., Pedersen, B. K., Al-Soud, W. A., Sørensen, S. J., Hansen, L. H., & Jakobsen, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009085 · Cited by 2,952
Lacy, B. E., Mearin, F., Chang, L., Chey, W. D., Lembo, A. J., Simren, M., & Spiller, R. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.031 · Cited by 2,866 · cited 1×
“%) of defecations; (e) fewer than three spontaneous bowel movement (SBM) per week; (f) loose stools rarely present without the use of laxatives; and (g) insufficient criteria for irritable bowel syndrome [9].”
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes.
Perkovic, V., Tuttle, K. R., Rossing, P., Mahaffey, K. W., Mann, J. F. E., Bakris, G., Baeres, F. M. M., Idorn, T., Bosch-Traberg, H., Lausvig, N. L., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2403347 · Cited by 2,099 · cited 1×
“Moreover, certain GLP-1 RAs, such as liraglutide, dulaglutide, and semaglutide in both formulations, have demonstrated CV and renal benefits [66–68].”
GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art
Nauck, M. A., Quast, D. R., Wefers, J., & Meier, J. J. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101102 · Cited by 1,647 · cited 3×
“Moreover, certain GLP-1 RAs, such as liraglutide, dulaglutide, and semaglutide in both formulations, have demonstrated CV and renal benefits [66–68].”
The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss
Secher, A., Jelsing, J., Baquero, A. F., Hecksher-Sørensen, J., Cowley, M. A., Dalbøge, L. S., Hansen, G., Grove, K. L., Pyke, C., Raun, K., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci75276 · Cited by 961 · cited 1×
“POMC/CART neurons that express GLP-1 receptors activate PB neurons and directly or indirectly suppress NPY/AgRP neurons [69,70], leading to disinhibition of suppressive signals to the PB.”
Epidemiology of constipation in children and adults: A systematic review
Mugie, S. M., Benninga, M. A., & Di Lorenzo, C. (2011) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2010.12.010 · Cited by 941
American Gastroenterological Association Technical Review on Constipation
Bharucha, A. E., Pemberton, J. H., & Locke, G. R. (2013) · Gastroenterology · doi:10.1053/j.gastro.2012.10.028 · Cited by 909 · cited 1×
“It is even more prevalent among older adults and those with lower socioeconomic status [12].”
Semaglutide lowers body weight in rodents via distributed neural pathways.
Gabery, S., Salinas, C. G., Paulsen, S. J., Ahnfelt-Rønne, J., Alanentalo, T., Baquero, A. F., Buckley, S. T., Farkas, E., Fekete, C., Frederiksen, K. S., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.133429 · Cited by 717 · cited 1×
“POMC/CART neurons that express GLP-1 receptors activate PB neurons and directly or indirectly suppress NPY/AgRP neurons [69,70], leading to disinhibition of suppressive signals to the PB.”
Disorders of gastrointestinal motility associated with diabetes mellitus
FELDMAN, M., & SCHILLER, L. R. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-3-378 · Cited by 653 · cited 1×
“The prevalence of constipation is greater in individuals with DM compared to the general population: in a study on 136 subjects [13], almost 60% had constipation symptoms, whereas other studies have found a prevalence ranging from 11 to 56% [14,15].”
Bytzer, P., Talley, N. J., Leemon, M., Young, L. J., Jones, M. P., & Horowitz, M. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.16.1989 · Cited by 632
A placebo-controlled trial of prucalopride for severe chronic constipation
Camilleri, M., Kerstens, R., Rykx, A., & Vandeplassche, L. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0800670 · Cited by 576
Systematic review: impact of constipation on quality of life in adults and children
BELSEY, J., GREENFIELD, S., CANDY, D., & GERAINT, M. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04273.x · Cited by 551 · cited 1×
“Constipation is associated not only with a diminished quality of life (QoL) [16] but also with an elevated risk of cardiovascular disease (CVD) and premature mortality [17,18].”
Mechanism of action of dietary fibre in the human colon
Stephen, A. M., & Cummings, J. H. (1980) · Nature · doi:10.1038/284283a0 · Cited by 499 · cited 1×
“Dietary fiber is defined as a plant-derived material resistant to digestion by human enzymes [87].”
Fermentation in the human large intestine and the available substrates
Cummings, J. H., & Englyst, H. N. (1987) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/45.5.1243 · Cited by 490 · cited 1×
“However, there is insufficient information on the efficacy and safety of PEG in people with DM, whereas lactulose may have a positive effect on glycemic control because of its fermentation products in the colon, which may disrupt glucose metabolism by reducing glucose hepatic production [101].”
Relationships of Upper Gastrointestinal Motor and Sensory Function With Glycemic Control
Rayner, C. K., Samsom, M., Jones, K. L., & Horowitz, M. (2001) · Diabetes Care · doi:10.2337/diacare.24.2.371 · Cited by 460 · cited 1×
“As a matter of fact, chronic hyperglycemia may further lead to macroangiopathy and vascular complications, potentially resulting in intestinal ischemia and impairing nerve and colonic muscle function [48].”
Schvarcz, E., Palmer, M., Aman, J., Horowitz, M., Stridsberg, M., & Berne, C. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70080-5 · Cited by 416 · cited 2×
“In individuals with DM, hyperglycemia may inhibit long and short neural reflexes that influence colonic motility [43].”
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes
McGuire, D. K., Marx, N., Mulvagh, S. L., Deanfield, J. E., Inzucchi, S. E., Pop-Busui, R., Mann, J. F. E., Emerson, S. S., Poulter, N. R., Engelmann, M. D. M., et al. (2025) · New England Journal of Medicine · doi:10.1056/nejmoa2501006 · Cited by 416
Nauck, M. A., Quast, D. R., Wefers, J., & Pfeiffer, A. F. H. (2021) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14496 · Cited by 388 · cited 1×
“However, there appear to be no direct effects on GI motility [74].”
Twenty four hour manometric recording of colonic motor activity in healthy man.
Narducci, F., Bassotti, G., Gaburri, M., & Morelli, A. (1987) · Gut · doi:10.1136/gut.28.1.17 · Cited by 379 · cited 1×
“Despite this, the day-night pattern of colonic contractility, characterized by increased contractility from night to morning [33], is maintained in people with T1DM and distal symmetric polyneuropathy [34].”
Self-citationQUIGLEY, E. M. M., VANDEPLASSCHE, L., KERSTENS, R., & AUSMA, J. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03884.x · Cited by 344 · cited 1×
“…inclusion criteria (laxative-refractory patients, with 80% experiencing less than one spontaneous complete bowel movement per week) showed that prucalopride was linked to an increase in bowel frequency to more than three per week in 24% of patients, compared with 11% in the placebo group [104–106].”
Johanson, J. F., Morton, D., Geenen, J., & Ueno, R. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01524.x · Cited by 331 · cited 1×
“Lubiprostone has been shown to be effective in promoting spontaneous bowel movements and relieving self-reported symptoms of chronic constipation [107–109].”
Bran and irritable bowel syndrome: time for reappraisal
FRANCIS, C. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91055-3 · Cited by 315 · cited 1×
“Despite controlled trials providing some evidence supporting the efficacy of high-fiber diets, this treatment is ineffective in restoring bowel movements in up to 40% of individuals, particularly those with impaired defecation or slow transit [89,90].”
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Eichorst, B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s005 · Cited by 305 · cited 2×
“Furthermore, evidence supports encouraging all subjects to reduce sedentary time by briefly standing, walking, or performing other light physical activities at least every 30 min [91].”
Diagnosis and treatment of chronic constipation - a European perspective
Tack, J., Müller-Lissner, S., Stanghellini, V., Boeckxstaens, G., Kamm, M. A., Simren, M., Galmiche, J.-P., & Fried, M. (2011) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2011.01709.x · Cited by 304 · cited 1×
“This class of drugs, available in various oral or intrarectal formulations, facilitates bowel movements by softening the stool and/or indirectly stimulating colonic motility through diverse mechanisms [92].”
Constipation and risk of death and cardiovascular events
Sumida, K., Molnar, M. Z., Potukuchi, P. K., Thomas, F., Lu, J. L., Yamagata, K., Kalantar-Zadeh, K., & Kovesdy, C. P. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.12.021 · Cited by 287 · cited 2×
“…constipation and the use of laxatives were independently associated with an increased risk of all-cause mortality and incident CV events, such as coronary heart disease (CHD) and ischemic stroke, in a large cohort of over 3 million US veterans monitored over a 7-year follow-up period [18].”
Gastrointestinal tract symptoms among persons with diabetes mellitus in the community
Maleki, D., Locke, G. R., Camilleri, M., Zinsmeister, A. R., Yawn, B. P., Leibson, C., & Melton, L. J. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.18.2808 · Cited by 282 · cited 1×
“The prevalence of constipation is greater in individuals with DM compared to the general population: in a study on 136 subjects [13], almost 60% had constipation symptoms, whereas other studies have found a prevalence ranging from 11 to 56% [14,15].”
Advances in the diagnosis and classification of gastric and intestinal motility disorders
on behalf of the International Working Group for Disorders of Gastrointestinal Motility and Function, Keller, J., Bassotti, G., Clarke, J., Dinning, P., Fox, M., Grover, M., Hellström, P. M., Ke, M., Layer, P., et al. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2018.7 · Cited by 265 · cited 1×
“There are various validated techniques for assessing colon transit, including the use of radiopaque markers, colonic transit scintigraphy, and the wireless motility capsule [82].”
Self-citationLiu, L., Chen, J., Wang, L., Chen, C., & Chen, L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1043789 · Cited by 258 · cited 1×
“Overall, GLP-1 RAs were associated with increased risk of GI disorders (OR, 1.46; 95% CI, 1.44–1.49) [71].”
InfluentialMarkland, A. D., Palsson, O., Goode, P. S., Burgio, K. L., Busby-Whitehead, J., & Whitehead, W. E. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.73 · Cited by 254 · cited 1×
“According to a previous systematic investigation, the prevalence of constipation in the general population ranged from 0.7% to 79%, with a median of 16% [10], with a greater rate in women (10.2% vs. 4% in men) [11].”
InfluentialAn Evidence-Based Approach to the Management of Chronic Constipation in North America
American College of Gastroenterology Chronic Constipation Task Force (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.50613_1.x · Cited by 249
Pelvic floor: anatomy and function
Bharucha, A. E. (2006) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2006.00803.x · Cited by 237 · cited 1×
“Given that the anal canal wall and the skin in the anal region are innervated by pudendal nerve fibers [60], discomfort in the anal region could serve as additional evidence of polyneuropathy.”
Yarandi, S. S., & Srinivasan, S. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12330 · Cited by 236 · cited 1×
“Peripheral DAN can affect the ENS and sensory nerves [23,24].”
JOHANSON, J. F., & UENO, R. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03320.x · Cited by 230
Chandrasekharan, B., Anitha, M., Blatt, R., Shahnavaz, N., Kooby, D., Staley, C., Mwangi, S., Jones, D. P., Sitaraman, S. V., & Srinivasan, S. (2011) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01611.x · Cited by 211 · cited 1×
“Chandrasekharan et al. demonstrated that colonic musculature in persons with DM does not contract and relax as effectively as that of healthy people, potentially due to the loss of nerve cells in the colon resulting from increased oxidative stress and apoptosis [31].”
Borner, T., Geisler, C. E., Fortin, S. M., Cosgrove, R., Alsina-Fernandez, J., Dogra, M., Doebley, S., Sanchez-Navarro, M. J., Leon, R. M., Gaisinsky, J., et al. (2021) · Diabetes · doi:10.2337/db21-0459 · Cited by 202 · cited 1×
“This finding may have a biological basis, given that GIP receptors are found in gamma-aminobutyric acid (GABAergic) neurons of the AP of the brain stem and contribute to the inhibition of neurons responsible for nausea and emesis [76].”
Psyllium is superior to docusate sodium for treatment of chronic constipation
McRorie, Daggy, Morel, Diersing, Miner, & Robinson (1998) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1998.00336.x · Cited by 201 · cited 1×
“Evidence from randomized, placebo-controlled trials (RCTs) indicates that psyllium husk can alleviate symptoms and provide natural relief from constipation by improving stool consistency and colonic transit time [93,94].”
Efficacy and safety of lubiprostone in patients with chronic constipation
Barish, C. F., Drossman, D., Johanson, J. F., & Ueno, R. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-1068-x · Cited by 192 · cited 1×
“Lubiprostone has been shown to be effective in promoting spontaneous bowel movements and relieving self-reported symptoms of chronic constipation [107–109].”
Babizhayev, M. A., Strokov, I. A., Nosikov, V. V., Savel'yeva, E. L., Sitnikov, V. F., Yegorov, Y. E., & Lankin, V. Z. (2014) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-014-0365-y · Cited by 168 · cited 1×
“Additionally, microvascular complications leading to neuropathy involve other biochemical pathways, such as oxidative stress, which is exacerbated by AGE production and polyol pathway activation [27], and the impairment of Na + , K + -ATPase activity in the cell membrane [28].”
Ward, S. M., & Sanders, K. M. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.117390 · Cited by 146 · cited 1×
“Furthermore, animal studies have demonstrated a decrease in the number of interstitial cells of Cajal (ICCs), the pacemaker cells in the GI tract, essential for the connection between the autonomic nervous system, enteric neurons, and smooth muscle cells [26].”
Therapeutic effects of psyllium in type 2 diabetic patients
Sierra, M., Garcia, J. J., Fernández, N., Diez, M. J., Calle, A., & Farmafibra Group (2002) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601398 · Cited by 136 · cited 1×
“One study found that psyllium also reduced the risk of coronary heart disease in subjects with T2DM [97].”
C‐peptide, Na+,K+‐ATPase, and Diabetes
Vague, P., Coste, T. C., Jannot, M. F., Raccah, D., & Tsimaratos, M. (2003) · Journal of Diabetes Research · doi:10.1080/15438600490424514 · Cited by 135 · cited 1×
“Additionally, microvascular complications leading to neuropathy involve other biochemical pathways, such as oxidative stress, which is exacerbated by AGE production and polyol pathway activation [27], and the impairment of Na + , K + -ATPase activity in the cell membrane [28].”
Badiali, D., Corazziari, E., Habib, F. I., Tomei, E., Bausano, G., Magrini, P., Anzini, F., & Torsoli, A. (1995) · Digestive Diseases and Sciences · doi:10.1007/bf02065421 · Cited by 127 · cited 1×
“Despite controlled trials providing some evidence supporting the efficacy of high-fiber diets, this treatment is ineffective in restoring bowel movements in up to 40% of individuals, particularly those with impaired defecation or slow transit [89,90].”
Bouhnik, Y., Neut, C., Raskine, L., Michel, C., Riottot, M., Andrieux, C., Guillemot, F., Dyard, F., & Flourié, B. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.01918.x · Cited by 121 · cited 1×
“For example, a randomized, triple-crossover study comparing PEG and lactulose in 57 patients showed that both agents were better than a placebo at improving stool frequency and ease of defecation [99], and similar results were found in another multicenter RCT conducted among 65 patients [100].”
Prevalence of gastrointestinal symptoms in diabetic patients and non-diabetic subjects.
Enck, P., Rathmann, W., Spiekermann, M., Czerner, D., Tschöpe, D., Ziegler, D., Strohmeyer, G. W., & Fa, G. (1994) · PubMed · Cited by 120
Nezami, B. G., Mwangi, S. M., Lee, J. E., Jeppsson, S., Anitha, M., Yarandi, S. S., Farris, A. B., & Srinivasan, S. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.10.053 · Cited by 119 · cited 1×
“…[51,52]; secondly, rats on a high-fat diet exhibit reduced serotonin levels in colon enterochromaffin cells compared to controls [53]; lastly, a high-fat diet may adversely affect human enteric neurons, similar to that observed in mice, through a pathway mediated by microRNA375 upregulation [54].”
Mechanisms of Constipation in Older Persons and Effects of Fiber Compared with Placebo
Cheskin, L. J., Kamal, N., Crowell, M. D., Schuster, M. M., & Whitehead, W. E. (1995) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1995.tb07203.x · Cited by 110 · cited 1×
“Evidence from randomized, placebo-controlled trials (RCTs) indicates that psyllium husk can alleviate symptoms and provide natural relief from constipation by improving stool consistency and colonic transit time [93,94].”
Diabetes Mellitus and the Colon
Piper, M. S., & Saad, R. J. (2017) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-017-0151-1 · Cited by 110 · cited 2×
“Among the various GI disturbances, constipation is particularly frequent in individuals with DM [8].”
Gastrointestinal symptoms in Chinese patients with Type 2 diabetes mellitus
Ko, G. T. C., Chan, W. ‐., Chan, J. C. N., Tsang, L. W. W., & Cockram, C. S. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00135.x · Cited by 109 · cited 1×
“In addition to being among the most prevalent GI complaints in DM, constipation represents the most severe symptomatic issue [55].”
Freedman, M. D., Schwartz, H. J., Roby, R., & Fleisher, S. (1997) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1997.tb04264.x · Cited by 106 · cited 1×
“For example, a randomized, triple-crossover study comparing PEG and lactulose in 57 patients showed that both agents were better than a placebo at improving stool frequency and ease of defecation [99], and similar results were found in another multicenter RCT conducted among 65 patients [100].”
The effects of capillary dysfunction on oxygen and glucose extraction in diabetic neuropathy
Østergaard, L., Finnerup, N. B., Terkelsen, A. J., Olesen, R. A., Drasbek, K. R., Knudsen, L., Jespersen, S. N., Frystyk, J., Charles, M., Thomsen, R. W., et al. (2014) · Diabetologia · doi:10.1007/s00125-014-3461-z · Cited by 104
Gastroparesis: New insights into an old disease
Usai–Satta, P., Bellini, M., Morelli, O., Geri, F., Lai, M., & Bassotti, G. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i19.2333 · Cited by 103
Self-citationEffect of high fat-diet and obesity on gastrointestinal motility.
Mushref, M. A., & Srinivasan, S. (2013) · PubMed · doi:10.3978/j.issn.2305-5839.2012.11.01 · Cited by 102 · cited 1×
“…a high-fat diet may activate the ileal brake, delaying gastric emptying and small bowel transit, thereby increasing the risk of constipation [51,52]; secondly, rats on a high-fat diet exhibit reduced serotonin levels in colon enterochromaffin cells compared to controls [53]; lastly, a…”
Bharucha, A. E., Low, P., Camilleri, M., Veil, E., Burton, D., Kudva, Y., Shah, P., Gehrking, T., & Zinsmeister, A. R. (2013) · Gut · doi:10.1136/gutjnl-2012-302483 · Cited by 98 · cited 1×
“Furthermore, compared to people without constipation, those with DM demonstrated longer colonic transit times [37].”
Upper gastrointestinal sensory-motor dysfunction in diabetes mellitus
Zhao, J.-B. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i18.2846 · Cited by 96 · cited 1×
“Gut sensory-motor disorders appear to be more prevalent in cases of more severe neuropathy [21].”
Elobixibat and its potential role in chronic idiopathic constipation
Acosta, A., & Camilleri, M. (2014) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x14528269 · Cited by 91 · cited 1×
“This agent is associated with decreased absorption of the bile acids (BAs) and enhanced delivery of BAs to the colon, which subsequently induces colonic contractility, water accumulation, and electrolyte secretion [111].”
Relation of symptoms to impaired stomach, small bowel, and colon motility in long-standing diabetes
Iber, F. L., Parveen, S., Vandrunen, M., Sood, K., Reza, F., Serlovsky, R., & Reddy, S. (1993) · Digestive Diseases and Sciences · doi:10.1007/bf01296772 · Cited by 91 · cited 1×
“This prolonged transit is most pronounced in men with long-term T1DM, where the overall colonic transit time is extended [32].”
Disturbed gastrointestinal motility and decreased interstitial cells of Cajal in diabetic db/db mice
Yamamoto, T., Watabe, K., Nakahara, M., Ogiyama, H., Kiyohara, T., Tsutsui, S., Tamura, S., Shinomura, Y., & Hayashi, N. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05326.x · Cited by 89 · cited 1×
“In db/db mice, prolonged transit time is associated with reduced expression of interstitial cells of Cajal (ICCs) and stem cell factor in the colon [38].”
Neri, L., Basilisco, G., Corazziari, E. S., Stanghellini, V., Bassotti, G., Bellini, M., Perelli, I., Cuomo, R., & LIRS Study Group (2014) · United European Gastroenterology Journal · doi:10.1177/2050640614528175 · Cited by 85 · cited 1×
“Constipation is associated not only with a diminished quality of life (QoL) [16] but also with an elevated risk of cardiovascular disease (CVD) and premature mortality [17,18].”
Self-citationDiabetic neuropathy in the gut: pathogenesis and diagnosis
Azpiroz, F., & Malagelada, C. (2015) · Diabetologia · doi:10.1007/s00125-015-3831-1 · Cited by 83 · cited 1×
“Peripheral DAN can affect the ENS and sensory nerves [23,24].”
Soltanian, N., & Janghorbani, M. (2019) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2018.11.002 · Cited by 82 · cited 1×
“Furthermore, it is recognized for its beneficial effects on blood pressure, cholesterol, and body weight [95,96].”
Aldhaleei, W. A., Abegaz, T. M., & Bhagavathula, A. S. (2024) · Pharmaceuticals · doi:10.3390/ph17020199 · Cited by 80 · cited 1×
“Conversely, a recent retrospective cross-sectional analysis utilizing real-world data from 10.328 adults with DM or obesity in the National Institutes of Health All of US cohort identified that 3.144 cases of constipation among new users of GLP-1 RAs who reported GI AEs [72].”
InfluentialConstipation in elderly long-stay patients: its treatment by magnesium hydroxide and bulk-laxative.
Kinnunen, O., & Salokannel, J. (1987) · PubMed · Cited by 77
Primary Care Management of Chronic Constipation in Asia: The ANMA Chronic Constipation Tool
Gwee, K.-A., Ghoshal, U. C., Gonlachanvit, S., Chua, A. S. B., Myung, S.-J., Rajindrajith, S., Patcharatrakul, T., Choi, M.-G., Wu, J. C. Y., Chen, M.-H., et al. (2013) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm.2013.19.2.149 · Cited by 77 · cited 2×
“According to the Rome IV criteria and the Asian Neurogastroenterology and Motility Association, patients who do not respond adequately to bulk-forming agents should first receive treatment with an osmotic laxative, followed by a stimulant laxative [88].”
Diabetes-induced mechanophysiological changes in the small intestine and colon
Zhao, M., Liao, D., & Zhao, J. (2017) · World Journal of Diabetes · doi:10.4239/wjd.v8.i6.249 · Cited by 74
Bharucha, A. E., & Wald, A. M. (2010) · The American Journal of Gastroenterology · doi:10.1038/ajg.2010.70 · Cited by 70 · cited 1×
“However, physiological tests can be performed to evaluate anorectal disorders in those who are not responding to initial treatment [80,81].”
Management of chronic constipation in patients with diabetes mellitus
Prasad, V. G. M., & Abraham, P. (2016) · Indian Journal of Gastroenterology · doi:10.1007/s12664-016-0724-2 · Cited by 69 · cited 2×
“Stimulant laxatives, including bisacodyl , senna , and sodium picosulfate , directly stimulate peristalsis and sensory nerve endings, and they are usually used on a short-term basis, with effect commencing within 6 to 12 h [85].”
Jin, B., Ha, S. E., Wei, L., Singh, R., Zogg, H., Clemmensen, B., Heredia, D. J., Gould, T. W., Sanders, K. M., & Ro, S. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.04.040 · Cited by 68
Noureddin, S., Mohsen, J., & Payman, A. (2018) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2018.07.004 · Cited by 67 · cited 1×
“Furthermore, it is recognized for its beneficial effects on blood pressure, cholesterol, and body weight [95,96].”
Taba Taba Vakili, S., Nezami, B. G., Shetty, A., Chetty, V. K., & Srinivasan, S. (2015) · Neurogastroenterology & Motility · doi:10.1111/nmo.12630 · Cited by 63 · cited 1×
“After multivariable adjustment, a diet high in saturated fats (exceeding 30 g daily) remained significantly associated with constipation [50].”
Pilot Study of Pathophysiology of Constipation Among Community Diabetics
Maleki, D., Camilleri, M., Burton, D. D., Rath-Harvey, D. M., Oenning, L., Pemberton, J. H., & Low, P. A. (1998) · Digestive Diseases and Sciences · doi:10.1023/a:1026657426396 · Cited by 63 · cited 1×
“Similar to idiopathic chronic constipation, both colonic dysmotility and anorectal dysfunctions (i.e., impaired anal sphincteric relaxation during defecation) may contribute to constipation in DM [19].”
Glucosensing in the gastrointestinal tract: Impact on glucose metabolism
Fournel, A., Marlin, A., Abot, A., Pasquio, C., Cirillo, C., Cani, P. D., & Knauf, C. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00015.2016 · Cited by 62 · cited 1×
“Specialized cells known as glucosensors, distributed throughout the gastrointestinal (GI) tract, are able to detect fluctuations in glucose levels and, in response, transmit hormonal/neuronal signals to regulate glycemia in tissues involved in glucose metabolism [2].”
Gut sensations in diabetic autonomic neuropathy
Frøkjær, J. B., Due Andersen, S., Ejskjær, N., Funch-Jensen, P., Arendt-Nielsen, L., Gregersen, H., & Drewes, A. M. (2007) · Pain · doi:10.1016/j.pain.2007.04.009 · Cited by 61
The Prevalence of Gastrointestinal Symptoms in Patients with Non-Insulin Dependent Diabetes Mellitus
Oh, J. H., Choi, M., Kang, M., Lee, K., Kim, J. I., Kim, B., Lee, D.-S., Kim, S.-S., Choi, H., Han, S.-W., et al. (2009) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2009.24.4.309 · Cited by 61
Specific inhibition of bile acid transport alters plasma lipids and GLP-1
Rudling, M., Camilleri, M., Graffner, H., Holst, J. J., & Rikner, L. (2015) · BMC Cardiovascular Disorders · doi:10.1186/s12872-015-0070-9 · Cited by 60 · cited 1×
“These findings corroborate initial studies that demonstrated the benefits of elobixibat on lipid and glucose metabolism, particularly through the elevation of GLP-1 plasma levels [114,115].”
Linaclotide for the treatment of chronic constipation
Bassotti, G., Usai–Satta, P., & Bellini, M. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1494728 · Cited by 58 · cited 1×
“Phase III results indicated that linaclotide improved bowel function in 20% of the patients, with consistent significant improvement in abdominal symptoms, global measures of constipation, and QoL [110].”
Self-citationPathophysiology and management of diabetic gastroenteropathy
Meldgaard, T., Keller, J., Olesen, A. E., Olesen, S. S., Krogh, K., Borre, M., Farmer, A., Brock, B., Brock, C., & Drewes, A. M. (2019) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284819852047 · Cited by 56 · cited 1×
“The cumulative effect of DM on the GI tract is termed “Diabetic gastroenteropathy” [4].”
Diabetic factors associated with gastrointestinal symptoms in patients with type 2 diabetes
Kim, J. H. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i14.1782 · Cited by 56
Caruso, I., Di Gioia, L., Di Molfetta, S., Cignarelli, A., Palmer, S. C., Natale, P., Strippoli, G. F. M., Perrini, S., Natalicchio, A., Laviola, L., et al. (2023) · eClinicalMedicine · doi:10.1016/j.eclinm.2023.102181 · Cited by 54 · cited 1×
“Several studies have confirmed the superiority of tirzepatide in reducing HbA 1c levels and body weight compared to GLP-1 RAs and other antidiabetic medications [73].”
Caruso, I., Di Gioia, L., Di Molfetta, S., Caporusso, M., Cignarelli, A., Sorice, G. P., Laviola, L., & Giorgino, F. (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-024-02441-z · Cited by 49 · cited 2×
“Notably, recent data from the FAERS database exhibited a lower incidence of nausea and vomiting compared to GLP-1 RAs [75].”
Bassotti, G., Usai–Satta, P., & Bellini, M. (2021) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s256364 · Cited by 49 · cited 1×
“Routine comprehensive diagnostic and physiological tests are not recommended [77,79].”
Self-citationForrest, A. S., Huizinga, J. D., Wang, X., Liu, L. W. C., & Parsons, M. E. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00196.2007 · Cited by 49 · cited 1×
“Nonetheless, the loss and damage to ICC in the submucosa and muscle layers are also correlated with increased contractility [42].”
Elobixibat for the treatment of constipation
Chedid, V., Vijayvargiya, P., & Camilleri, M. (2018) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2018.1522248 · Cited by 48 · cited 1×
“These findings corroborate initial studies that demonstrated the benefits of elobixibat on lipid and glucose metabolism, particularly through the elevation of GLP-1 plasma levels [114,115].”
Ihana‐Sugiyama, N., Nagata, N., Yamamoto‐Honda, R., Izawa, E., Kajio, H., Shimbo, T., Kakei, M., Uemura, N., Akiyama, J., & Noda, M. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i11.3252 · Cited by 48
Novel insights into the pathogenic impact of diabetes on the gastrointestinal tract
Portincasa, P., Bonfrate, L., Wang, D. Q. ‐., Frühbeck, G., Garruti, G., & Ciaula, A. D. (2022) · European Journal of Clinical Investigation · doi:10.1111/eci.13846 · Cited by 46 · cited 1×
“Although DM involvement, particularly concerning sensorimotor functions, may occur from the esophagus to the anorectum [5], the most well-documented, frequent, and significant abnormalities have been observed in the stomach [6,7].”
Annese, V., Lombardi, G., Frusciante, V., Germani, U., Andriulli, A., & Bassotti, G. (1997) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1997.00177.x · Cited by 42 · cited 1×
“Although DM involvement, particularly concerning sensorimotor functions, may occur from the esophagus to the anorectum [5], the most well-documented, frequent, and significant abnormalities have been observed in the stomach [6,7].”
Self-citationThe physiological basis of insulin therapy in people with diabetes mellitus
Bolli, G. B., Porcellati, F., Lucidi, P., & Fanelli, C. G. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108839 · Cited by 42 · cited 1×
“The major types of DM are type 1 (T1DM) and type 2 (T2DM), with T2DM being significantly more prevalent, accounting for over 90% of adult cases [1].”
Self-citationSerotonin availability in rat colon is reduced during a Western diet model of obesity
Bertrand, R. L., Senadheera, S. N., Tanoto, A., Tan, K. L., Howitt, L., Chen, H., Murphy, T. V., Sandow, S. L., Liu, L., & Bertrand, P. P. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00048.2012 · Cited by 37 · cited 1×
“…of constipation [51,52]; secondly, rats on a high-fat diet exhibit reduced serotonin levels in colon enterochromaffin cells compared to controls [53]; lastly, a high-fat diet may adversely affect human enteric neurons, similar to that observed in mice, through a pathway mediated by microRNA375…”
The Pathophysiology, Diagnosis and Treatment of Constipation
Müller-Lissner, S. A. (2009) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2009.0424 · Cited by 37
A practical approach to diagnosis and management of functional constipation in adults
Bassotti, G., & Villanacci, V. (2011) · Internal and Emergency Medicine · doi:10.1007/s11739-011-0698-0 · Cited by 36 · cited 1×
“A higher-fiber diet, increased water intake, and regular physical activity are integral components of a healthy lifestyle that should be promoted for the patients [86].”
Self-citationDisorders of colonic motility in patients with diabetes mellitus.
Battle, W. M., Cohen, J. D., & Wj, S. (1983) · PubMed Central · Cited by 35
Brain changes in diabetes mellitus patients with gastrointestinal symptoms
Drewes, A. M. (2016) · World Journal of Diabetes · doi:10.4239/wjd.v7.i2.14 · Cited by 35 · cited 1×
“More than 30% of long-standing subjects with DM exhibit DAN, making it one of the most prevalent complications of DM, and it is correlated with other GI complications [22].”
Reszczyńska, M., & Kempiński, R. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10030415 · Cited by 32
Prucalopride for the treatment of constipation: a view from 2015 and beyond
Bassotti, G., Usai–Satta, P., & Bellini, M. (2019) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2019.1568238 · Cited by 31 · cited 1×
“…inclusion criteria (laxative-refractory patients, with 80% experiencing less than one spontaneous complete bowel movement per week) showed that prucalopride was linked to an increase in bowel frequency to more than three per week in 24% of patients, compared with 11% in the placebo group [104–106].”
Self-citationLeeds, J. S., Hadjivassiliou, M., Tesfaye, S. H., & Sanders, D. S. (2018) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2018-000514 · Cited by 31 · cited 3×
“DAN, retinopathy, diabetic kidney disease (DKD), and joint problems were primarily associated with alternating bowel habits and diarrhea, whereas no complications were found to be correlated with constipation alone [62].”
InfluentialCurrent management strategies and therapeutic targets in chronic constipation
Emmanuel, A. V. (2010) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x10384173 · Cited by 27 · cited 1×
“Some osmotic laxatives can cause gas, nausea, and bloating in the abdomen [98].”
Segmental gut transit in diabetes mellitus: effect of cisapride
Kawagishi, T., Nishizawà, Y., Okuno, Y., Sekiya, K., & Morii, H. (1992) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(92)90159-o · Cited by 27 · cited 1×
“Subjects with DM and DAN may experience delayed transit throughout the GI tract, particularly evident in the distal colon [30].”
Yamada, E., Namiki, Y., Takano, Y., Takamine, H., Inazumi, K., Sasaki, H., Yamada, M., Ito, S., Iwasaki, T., Mantani, N., et al. (2017) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14022 · Cited by 26 · cited 1×
“[63].”
Effect of acute hyperglycemia on colorectal motor and sensory function in humans
Maleki, D., Camilleri, M., Zinsmeister, A. R., & Rizza, R. A. (1997) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1997.273.4.g859 · Cited by 24
Ito, H., Ito, K., Tanaka, M., Mayumi, H., Tanaka, M., Kusano, E., Kondo, J., Izutsu, T., Matsumoto, S., Inoue, H., et al. (2022) · Internal Medicine · doi:10.2169/internalmedicine.7676-21 · Cited by 18 · cited 1×
“The authors of this study hypothesized that the mechanisms underlying constipation in persons with CHD may involve somatic venous congestion due to increased right atrial pressure and the effects of certain drugs, such as diuretics, beta-blockers, and calcium channel blockers [64].”
Fano, M. D., Porcellati, F., Fanelli, C. G., Corio, S., Mazzieri, A., Lucidi, P., Bolli, G. B., & Bassotti, G. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110828 · Cited by 15
Self-citationDefecation frequency and glycemic control in patients with diabetes: The Fukuoka Diabetes Registry
Ohkuma, T., Iwase, M., Fujii, H., Ide, H., Komorita, Y., Yoshinari, M., Oku, Y., Higashi, T., Nakamura, U., & Kitazono, T. (2020) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2020.107751 · Cited by 11 · cited 1×
“Regarding chronic hyperglycemia, Ohkuma and colleagues assessed the relationship between defecation frequency and HbA 1c in 5131 people with DM from the Fukuoka Diabetes Registry, a multi-center prospective cohort study conducted in a diabetes specialist outpatient clinic [45].”
Hishida, Y., Nagai, Y., Tsukiyama, H., Nakamura, Y., Nakagawa, T., Ishizaki, S., Tanaka, Y., & Sone, M. (2022) · Advances in Therapy · doi:10.1007/s12325-022-02243-w · Cited by 10 · cited 1×
“…of treatment, elobixibat significantly increased the median frequency of spontaneous bowel movements per week and improved the QoL related to constipation, as assessed by the Japanese version of the Patient Assessment of Constipation Quality of Life, without the occurrence of serious AEs [112].”
Gastrocolic Reflex Is Delayed and Diminished in Adults with Type 1 Diabetes
Wegeberg, A., Liao, D., Jensen, S. L., Sørensen, P. S., Wigh, I. M. N., Zaugg, V. S., & Brock, C. (2022) · Digestive Diseases and Sciences · doi:10.1007/s10620-021-07346-y · Cited by 9 · cited 1×
“Notably, the gastrocolic reflex appears to be delayed and diminished, particularly in people with concurrent autonomic or peripheral neuropathy [35].”
Considerations for laxatives in terms of their interactions with other drugs
Bassotti, G., & Battaglia, E. (2023) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2023.2193326 · Cited by 9 · cited 1×
“…pharmacological treatment, further information is anticipated concerning the potential to address alterations in the intestinal microbiota, which is known to underlie several chronic diseases, as well as the eventual drug interactions between laxatives and other concomitant treatments [117].”
Self-citationConstipation and diabetic kidney disease: The Fukuoka Diabetes Registry
Ohkuma, T., Iwase, M., Fujii, H., Ide, H., Komorita, Y., Yoshinari, M., Oku, Y., Higashi, T., Oshiro, A., Nakamura, U., et al. (2021) · Clinical and Experimental Nephrology · doi:10.1007/s10157-021-02105-9 · Cited by 8 · cited 1×
“Potential mechanisms for this association include those previously mentioned: alterations in gut microbiota (leading to the accumulation of uremic toxins), increased serotonin levels, and the use of laxatives [65].”
Yoshinobu, S., Hasuzawa, N., Nagayama, A., Iwata, S., Yasuda, J., Tokubuchi, R., Kabashima, M., Gobaru, M., Hara, K., Murotani, K., et al. (2022) · Clinical Therapeutics · doi:10.1016/j.clinthera.2022.08.009 · Cited by 7 · cited 1×
“Another single-arm study, conducted with 21 individuals with T2DM and constipation, revealed a significant positive impact of elobixibat treatment on HbA 1c levels and a reduction in LDL cholesterol [113].”
Bassotti, G. (2023) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2023.2267968 · Cited by 7 · cited 1×
“It must also be remembered that constipated patients with scarce control of symptoms are often treated (or self-treated) by mechanical methods (enemas) [116].”
Self-citationDiabetes and gastrointestinal motor activity.
Bassotti, G. (1991) · PubMed · Cited by 7
Self-citationJorge, J. X., Matos, H. C., Machado, J. P., & Almeida, C. C. (2012) · Revista Española de Enfermedades Digestivas · doi:10.4321/s1130-01082012000300003 · Cited by 6 · cited 1×
“However, at 72 h post-ingestion, significantly fewer markers were found in healthy subjects [36].”
Sun, M., Wang, F., & Feng, P. (2014) · Regulatory Peptides · doi:10.1016/j.regpep.2014.11.005 · Cited by 5 · cited 1×
“Treatment with insulin-like growth factor 1 (IGF-1) has been shown to prevent apoptosis of colonic smooth muscle cells and improve colon motility in rats with DM [40].”
Constipation and glycemic control
Conway, R. B. N., Peltier, A., & Figaro, M. K. (2020) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2020.107799 · Cited by 4 · cited 1×
“Additionally, the authors did not address bloating, diarrhea, early satiety, or other GI symptoms [49].”
Jorge, J. X., Borges, C. I. C., Panão, E. A., Delgado, F. J., Simões, M. A., Coelho, Á. C., Silva, A. L., & Almeida, C. C. (2013) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2012.09.009 · Cited by 4 · cited 2×
“Additionally, individuals with a severe sensation of incomplete defecation experienced anal discomfort, especially evident in people with long-standing DM and DAN symptoms [59].”
Jensen, M. M., Wegeberg, A., Jensen, S. L., Sørensen, P. S., Wigh, I. M. N., Zaugg, V. S., Færch, K., Quist, J. S., & Brock, C. (2021) · Chronobiology International · doi:10.1080/07420528.2021.1890761 · Cited by 3 · cited 1×
“Despite this, the day-night pattern of colonic contractility, characterized by increased contractility from night to morning [33], is maintained in people with T1DM and distal symmetric polyneuropathy [34].”
Lambiase, C., D’Alba, L., Galeazzi, F., Bassotti, G., Consalvo, D., Battaglia, E., Cataudella, G., Neri, M. C., Londoni, C., Rossitti, P., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13206047 · Cited by 3 · cited 1×
“However, these studies are invasive and usually only available in specialized centers [83].”
Self-citationQuan, X., Chen, W., Liang, C., Jia, Y., Wang, Y., Luo, H., & Wang, J. (2023) · Neurogastroenterology & Motility · doi:10.1111/nmo.14647 · Cited by 3 · cited 1×
“Additional contributing factors include a reduction in cholinergic receptors and neuronal nitric oxide synthase in the proximal colon, as well as a downregulation of brain-derived neurotrophic factor (BDNF) and its receptor TrkB [39].”
Digital Rectal Examination: The Whole World is a Country!
Bellini, M., Usai–Satta, P., & Bassotti, G. (2018) · The American Journal of Gastroenterology · doi:10.1038/s41395-018-0286-2 · Cited by 2 · cited 1×
“Particularly in individuals with DM, a careful rectal examination should be carried out to screen for coexistent pelvic floor muscle dysfunction [78].”
Self-citationEditorial: Sonographic assessment of colonic content—A new tool for constipation?
Maconi, G., & Bassotti, G. (2024) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.18100 · Cited by 2
Self-citation
Cited by
Barana, L., De Fano, M., Cavallo, M., Manco, M., Prete, D., Fanelli, C. G., Porcellati, F., & Pippi, R. (2025) · Nutrients · doi:10.3390/nu18010131 · Cited by 13
“…from the FDA Adverse Event Reporting System indicate a lower incidence of nausea and vomiting, potentially due to GIP receptor-mediated neuronal inhibition in the area postrema [149,150], whereas constipation appears more frequent, with the underlying mechanisms yet to be fully elucidated [151].”
Self-citationZhou, X., You, G., Zhang, L., Fan, D., & Yue, C. (2026) · Journal of Molecular Histology · doi:10.1007/s10735-026-10741-2 · Cited by 1
Shao, M., Zhu, T., Hu, X., Fang, X., Pan, X., Wen, L., Dai, P., Amdanee, N., Zhang, L., Xu, Y., et al. (2026) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253261432764
“Diabetic enteropathy or enteric neuropathy that affects colonic transit has been associated with both diarrhea and constipation, 91–93 which might independently contribute to or modify the presentation of AIC.”
Elmezayen, Z. W., Qrareya, F., Abdallah, A., Salameh, H., & Qaisi, W. (2026) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.1177/11795514261443862
“20 Another key implication highlighted by this case is the importance of maintaining adequate caloric and protein intake during rapid weight loss induced by GLP-1 receptor agonists.”
Kurniasari, A. F., & Susanti, N. (2026) · Indonesian Journal of Case Reports
Metadata
- Authors
- De Fano, M., Baluganti, S., Manco, M., Porcellati, F., Fanelli, C. G., & Bassotti, G.
- Affiliations
- Endocrine and Metabolic Sciences Section, Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy
- University of Perugia (IT)
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2025-09-24
- Volume
- 17
- Issue
- 19
- Pages
- 3038
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC12526187
- OpenAlex
- W4414480209
- Cited by
- 4
- References
- 114
- Citations by year
- 2026: 3 · 2025: 1
- FWCI
- 0.95
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Urology › Pelvic floor disorders treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- chronic constipation, diabetes mellitus, GLP-1 receptor agonists, type 2 diabetes, hyperglycemia, colonic transit, laxatives
- MeSH terms
- Colon, Constipation, Diabetes Mellitus, Type 2, Gastrointestinal Motility, Humans, Diabetes Complications, Glucagon-Like Peptide 1, Laxatives
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

